Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial
Gut and Liver · 2026
DOI: 10.5009/gnl250435 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Gut and Liver, 2026. Verfasst von Myeongseok Koh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Dong-A University Hospital, Busan, Korea. Hauptthemen laut MEDLINE: Helicobacter Infections, Metronidazole, Tetracycline, Helicobacter pylori. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean College of Helicobacter and Upper Gastrointestinal Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Dong-A University Hospital, Busan, Korea.
- Department of Internal Medicine, Medical Research Institute, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Ho…
- Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
- Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
- Department of Internal Medicine, Pusan National University Hospital, Busan, Korea.
- Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
ORCID-Profile: Myeongseok Koh, Cheol Woong Choi, Dae Gon Ryu, Seung Jung Yu, Sung Eun Kim, Kyoungwon Jung, Bong Eun Lee, Moon Won Lee, Dong Chan Joo, Jin Lee, Ra Ri Cha, Sam Ryong Jee
Förderung
- Korean College of Helicobacter and Upper Gastrointestinal Research Foundation
Zitieren
APA
Koh, M., Choi, C. W., Ryu, D. G., Yu, S. J., Kim, S. E., Jung, K., Lee, B. E., Lee, M. W., Joo, D. C., Lee, J., Cha, R. R., & Jee, S. R. (2026). Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial. Gut and Liver. https://doi.org/10.5009/gnl250435
Vancouver
Koh M, Choi CW, Ryu DG, Yu SJ, Kim SE, Jung K, et al. Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial. Gut and Liver. 2026. doi:10.5009/gnl250435
BibTeX
@article{Koh2026,
author = {Koh, Myeongseok and Choi, Cheol Woong and Ryu, Dae Gon and Yu, Seung Jung and Kim, Sung Eun and Jung, Kyoungwon and Lee, Bong Eun and Lee, Moon Won and Joo, Dong Chan and Lee, Jin and Cha, Ra Ri and Jee, Sam Ryong},
title = {Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial},
journal = {Gut and Liver},
year = {2026},
doi = {10.5009/gnl250435}
}
EUVIMED